Merck KGaA (ETR:MRK)
Germany · Delayed Price · Currency is EUR 131.00
+0.25 (0.19%)
Jun 3, 2026, 10:11 AM CET
Revenue
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Process Solutions Revenue | 3.88B | 3.79B | 3.52B | ||||||||||||
Process Solutions Revenue Growth | 2.44% | 7.46% | -6.87% | ||||||||||||
Life Science Services Revenue | - | - | 721.80M | ||||||||||||
Life Science Services Revenue Growth | - | - | -8.89% | ||||||||||||
Science & Lab Solutions Revenue | - | - | 4.67B | ||||||||||||
Science & Lab Solutions Revenue Growth | - | - | -0.73% | ||||||||||||
Oncology Revenue | 1.88B | 1.93B | 2.01B | ||||||||||||
Oncology Revenue Growth | -2.13% | -4.17% | 10.47% | ||||||||||||
Neurology & Immunology Revenue | 1.60B | 1.66B | 1.69B | ||||||||||||
Neurology & Immunology Revenue Growth | -3.38% | -1.75% | 1.39% | ||||||||||||
Fertility Revenue | 1.42B | 1.46B | 1.53B | ||||||||||||
Fertility Revenue Growth | -2.70% | -4.64% | -1.27% | ||||||||||||
Cardiovascular, Metabolism and Endocrinology Revenue | 3.03B | 3.05B | 2.95B | ||||||||||||
Cardiovascular, Metabolism and Endocrinology Revenue Growth | -0.65% | 3.44% | 5.83% | ||||||||||||
Other Healthcare Revenue | 328.40M | 328.00M | 280.50M | ||||||||||||
Other Healthcare Revenue Growth | 0.12% | 16.93% | 19.16% | ||||||||||||
Surface Solutions Revenue | - | - | 406.50M | ||||||||||||
Surface Solutions Revenue Growth | - | - | -1.07% | ||||||||||||
Semiconductor Solutions Revenue | 2.49B | 2.50B | 2.63B | ||||||||||||
Semiconductor Solutions Revenue Growth | -0.42% | -5.12% | 6.13% | ||||||||||||
Advanced Solutions Revenue | 2.35B | 2.37B | - | ||||||||||||
Advanced Solutions Revenue Growth | -0.65% | - | - | ||||||||||||
Discovery Solutions Revenue | 2.80B | 2.83B | - | ||||||||||||
Discovery Solutions Revenue Growth | -1.03% | - | - | ||||||||||||
Total Life Science Revenue | 9.03B | 8.98B | 8.92B | ||||||||||||
Total Life Science Revenue Growth | 0.53% | 0.71% | -3.93% | ||||||||||||
Rare Diseases Revenue | - | 188.20M | - | ||||||||||||
Total Healthcare Revenue | 8.54B | 8.61B | 8.45B | ||||||||||||
Total Healthcare Revenue Growth | -0.73% | 1.81% | 4.98% | ||||||||||||
Optronics Revenue | 753.50M | 774.20M | 748.30M | ||||||||||||
Optronics Revenue Growth | -2.67% | 3.46% | -2.77% | ||||||||||||
Total Electronics Revenue | 3.38B | 3.51B | 3.79B | ||||||||||||
Total Electronics Revenue Growth | -3.74% | -7.15% | 3.45% | ||||||||||||
Revenue (Total) | 20.96B | 21.10B | 21.16B | ||||||||||||
Revenue (Total) Growth | -0.69% | -0.26% | 0.78% |
Revenue by Geography
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Europe Revenue | 6.46B | 6.42B | 6.17B | ||||||||||||
Europe Revenue Growth | 0.70% | 3.99% | 2.21% | ||||||||||||
North America Revenue | 5.46B | 5.52B | 5.71B | ||||||||||||
North America Revenue Growth | -1.07% | -3.37% | -4.06% | ||||||||||||
Asia Pacific Revenue | 6.87B | 6.94B | 7.02B | ||||||||||||
Asia Pacific Revenue Growth | -1.01% | -1.16% | 1.18% | ||||||||||||
Latin America Revenue | 1.44B | 1.45B | 1.48B | ||||||||||||
Latin America Revenue Growth | -0.68% | -2.02% | 10.91% | ||||||||||||
Middle East & Africa Revenue | 732.20M | 784.60M | 781.20M | ||||||||||||
Middle East & Africa Revenue Growth | -6.68% | 0.43% | 5.98% | ||||||||||||
Revenue (Other) | -100.00K | 100.00K | 300.00K | ||||||||||||
Revenue (Total) | 20.96B | 21.10B | 21.16B | ||||||||||||
Revenue (Total) Growth | -0.69% | -0.26% | 0.78% |
EBITDA
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
Life Science EBITDA | 2.61B | 2.59B | 2.59B | ||||||||||||
Life Science EBITDA Growth | 1.02% | -0.16% | -8.17% | ||||||||||||
Healthcare EBITDA | 3.00B | 3.08B | 2.99B | ||||||||||||
Healthcare EBITDA Growth | -2.51% | 2.83% | 17.75% | ||||||||||||
Electronics EBITDA | 870.40M | 832.60M | 969.60M | ||||||||||||
Electronics EBITDA Growth | 4.54% | -14.13% | 6.20% | ||||||||||||
Corporate/Others EBITDA | -379.90M | -388.30M | -481.80M | ||||||||||||
Operating Income (Other) | -2.57B | -2.51B | -2.43B | ||||||||||||
Operating Income (Total) | 3.53B | 3.60B | 3.65B | ||||||||||||
Operating Income (Total) Growth | -1.90% | -1.21% | 1.00% |
Updated May 13, 2026. Data Source: Fiscal.ai.